AHA 2020: Preclinical Presentation on Sotatercept in PAH
Updates from the ongoing PULSAR and SPECTRA Phase 2 clinical trials of sotatercept in patients with pulmonary arterial hypertension (PAH) will be presented at the American Heart Association (AHA) 2020 Scientific Sessions, held...
Read More